| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | -0.0099 | 0.8 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.09 | 0.8 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |